Porcine and bovine aortic endothelial cells and human colonic adenocarcinoma cells were compared for their susceptibility to the toxic effect of purified Shiga-like toxin IIe (SLT-IIe), measured by the neutral red cytotoxicity assay. Cytotoxicity correlated with toxin binding as indicated by fluorescence activated cell sorter analysis and with the globotriosylceramide (Gb3) and globotetraosylceramide (Gb4) content of cells determined by high pressure liquid chromatography. One line of porcine aortic endothelial cells was 1400-fold more susceptible than the line of bovine aortic endothelial cells that was tested, but a second line of porcine aortic endothelial cells was highly refractory to SLT-IIe. Human colonic adenocarcinoma cells lacked detectable levels of Gb4 and were least susceptible to SLT-IIe.
MarquesL. R. M.,
PeirisJ. S. M.,
CryzS. J.,
O’BrienA. D.Escherichia coli strains isolated from pigs with edema disease produce a variant of Shiga-like toxin II. FEMS Microbiol Lett1987; 44:33–38
MeyerT.,
KarchH. Genes coding for Shiga-like toxin and heat-stabile enterotoxin in porcine strains of Escherichia coli. FEMS Microbiol Lett1989; 58:115–120
StrockbineN. A.,
MarquesL. R. M.,
NewlandJ. W.,
SmithH. W.,
HolmesR. K.,
O’BrienA. D. Two toxin-converting phages from Escherichia coli 0157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun1986; 53:135–140
GylesC. L.,
DeGrandisS. A.,
MacKenzieC.,
BruntonJ. L. Cloning and nucleotide sequence analysis of the genes determining verocytotoxin production in a porcine edema disease isolate of Escherichia coli. Microb Pathog1988; 5:419–426
WeinsteinD. L.,
JacksonM. P.,
SamuelJ. E.,
HolmesR. K.,
O’BrienA. D. Cloning and sequencing of a Shiga-like toxin type II variant from an Escherichia coli strain responsible for edema disease of swine. J Bacteriol1988; 170:4223–1230
GannonV. P. J.,
GylesC. L. Characteristics of the Shiga-like toxin produced by Escherichia coli associated with porcine edema disease. Vet Microbiol1990; 24:89–100
DeGrandisS.,
LawH.,
BruntonJ.,
GylesC.,
LingwoodC. A. Globotetraosylceramide is recognized by the pig edema disease toxin. J Biol Chem1989; 264:12520–12525
KeuschG. T.,
JacewiczM.,
AchesonD. W. K.,
Donohue-RolfeA.,
KaneA. V.,
McCluerR. H. Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e. Infect Immun1995; 63:1138–1141
HeadS. C.,
KarmaliM. A.,
LingwoodC. A. Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. J Biol Chem1991; 266:3617–3621
ZojaC.,
ComaD.,
FarinaC. Verotoxin glycoplipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1. J Lab Clin Med1992; 120:229–238
MoyerM. P.,
DixonP. S.,
RothmanS. W.,
BrownJ. E. Cytotoxicity of Shiga toxin for primary cultures of human colonic and ileal epithelial cells. Infect Immun1987; 55:1533–1535
Valdivieso-GarciaA.,
RosendalS.,
AllenO. B.,
ThompsonC. M.,
WatsonS. Cytotoxicity of Mycoplasma mycoides subspecies mycoides for cultured endothelial cells. Int J Med Microbiol1989; 272:202–209
Valdivieso-GarciaA.,
ClarkeR. C.,
RahnK.,
DuretteA.,
MacLeodD. L.,
GylesC. L. Neutral red assay for measurement of quantitative vero cell cytotoxicity. Appl Environ Microbiol1993; 59:1981–1983
TyrrellG. J.,
RamotarK.,
ToyeB.,
BoydB.,
LingwoodC. A.,
BruntonJ. L. Alteration of the carbohydrate binding specificity of verotoxins from Galα1-4Gal to GalNAcß1-3 Galα1-4Gal and vice versa by site-directed mutagenesis of the binding subunit. Proc Natl Acad Sci USA1992; 89:524–528
GrantC. W. M. Cell surface structural implications of some experiments with isolated glycolipids and glycoproteins. Can J Biochem Cell Biol1984; 62:1151–1157
ForstnerG.,
ShermanP.,
ForstnerJ. Mucus: function and structure. In
BoedekerE. C.
(ed) Attachment of organisms to the gut mucosa vol II Boca Raton, LL: CRC Press Inc; 198414–20
BoydB.,
TyrrellG.,
MalonbeyM.,
GylesC.,
BruntonJ.,
LingwoodC. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs. J Exp Med1993; 177:1745–1753